Menu

Consolidated Income Statement1


Show table
28.5 KB EXCEL
€ million Note 2015 2014
Net sales ➞ 8 12,844.7 11,362.8
Cost of sales ➞ 9 – 4,076.3 – 3,526.4
(of which: amortization of intangible assets)2 (– 166.6) (– 94.0)
Gross profit 8,768.4 7,836.4
 
Marketing and selling expenses ➞ 10 – 4,049.5 – 3,589.1
(of which: amortization of intangible assets)2 (– 778.9) (– 719.0)
Administration expenses – 719.9 – 608.6
Research and development costs ➞ 11 – 1,709.2 – 1,703.7
(of which: amortization of intangible assets)2 (– 2.7) (– 3.8)
Other operating income ➞ 12 470.7 564.4
Other operating expenses ➞ 13 – 917.3 – 737.4
Operating result (EBIT) 1,843.2 1,762.0
 
Financial result ➞ 14 – 356.7 – 205.0
Profit before income tax 1,486.5 1,557.0
 
Income tax ➞ 15 – 368.0 – 392.2
Profit after tax from continuing operations 1,118.5 1,164.8
Profit after tax from discontinued operations 5.6
Profit after tax 1,124.1 1,164.8
 
of which: attributable to shareholders of Merck KGaA, Darmstadt, Germany (net income) 1,114.8 1,157.3
of which: attributable to non-controlling interests ➞ 25 9.3 7.5
 
Earnings per share (in €) ➞ 16  
basic 2.56 2.66
- thereof from continuing operations 2.55 2.66
- thereof from discontinued operations 0.01
 
diluted 2.56 2.66
- thereof from continuing operations 2.55 2.66
- thereof from discontinued operations 0.01
1
The reporting structure has changed, see “Changes to accounting and measurement principles and disclosure changes”.
2
Excluding amortization of internally generated or separately acquired software.